Italia markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
160,35+1,76 (+1,11%)
Alla chiusura: 04:00PM EDT
161,00 +0,65 (+0,41%)
Dopo ore: 07:51PM EDT

Yahoo Finanza Italia rimuoverà le nostre bacheche con le conversazioni il giorno 15 agosto. Grazie per essere un membro così fedele della nostra community di conversazioni di finanza!

Accedi per pubblicare un messaggio.
  • S
    Sell The News
    $NVAX conversation
  • B
    BeeSay
    $NVAX conversation
    Go figure - $BNTX has the vaccine that the president got only 3 months ago, and BUYERS swoop in to push their stock up. Meanwhile NVAX is barely green. Makes no sense whatsoever.
  • M
    Metal Ox
    Now $cvac suing $bntx for patent infringement, and some of the curevac patents involve LNP technology. Does cvac have license from $abus or one of its affiliates for LNP technology, or does cvac predate abus patents? Does curevac moves against bntx help or hurt abus legal claims, and push abus share price up or down?

    ——————
    BioNTech and Pfizer asked the Boston court to declare that their Comirnaty vaccine does not violate three CureVac patents related to RNA-based vaccines. The companies told the court that Comirnaty does not work in the same way as CureVac's patented technology.
    One of the patents concerns messenger RNA (mRNA) connected to lipid nanoparticles (LNPs), which the vaccines use to deliver the molecules safely into the body. Pfizer, BioNTech, and Moderna have been hit with U.S. patent lawsuits by other biotech companies this year over the LNP technology used in their vaccines.
  • T
    Titos
    $NVAX conversation
    FYI, Newscomau: "Not even vaccine-hesitant Aussies waiting for Novavax really wanted the jab". Just one per cent of Australia’s 51 million doses of this vaccine were used, while the rest of them face the prospect of being thrown out. Just 167,800 doses of the protein-based vaccine have been administered across the country up to July 14 this year, the TGA reports.

    The amount is minuscule compared to the more than 42 million Pfizer doses and almost 14 million AstraZeneca doses administered since their respective approvals in 2021. Meanwhile more than 4.7 million Moderna jabs are in arms across the country.

    “The Albanese government really needs to think about whether those doses (NVAX's) could be relinquished and funnelled through COVAX, the global mechanism for distributing vaccines,” Professor Gleeson said. “Sending them through COVAX would mean that they could be delivered to countries that are ready and able to take them and countries that need them the most.” $BNTX
  • S
    Sam
    $BNTX conversation
    I was waiting for some time now to buy some $bntx & $mrna. Thank you shorts for lowering the price! Just got in: 75% bntx, and 25% mrna. Good luck to you all!
  • P
    Peter-1
    $SIGA conversation
    Buy and hold for next few years
    Next $mrna or $bntx

    $siga will cross $300 soon
  • D
    Dawden
    $WIMI conversation
    $BNTX $WIMI $COIN
    Today's gonna be a crucial day. Lets see where we goes this week.
  • A
    Al
    Novavax, Inc.
    It is different proven superior technology than $BNTX & $MRNA
  • E
    Edward
    $MRNA conversation
    I'm really regretting my MRNA vaccination and booster. No more boosters for me. $BNTX

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012513/
  • i
    investfordummies
    $NVAX conversation
    Why the US gvt is buying $NVAX... even if not yet approved... and not $MRNA or $BNTX shots... They want $NVAX to produce ASAP... That's my reading.
  • i
    investfordummies
    $MRNA conversation
    188$ last resistance on $MRNA before flying
    $BNTX $NVAX
  • i
    investfordummies
    $NVAX conversation
    Let's assume, you are a fund manager... And don't have any NVAX, you wanted to play it safe and wait for FDA

    1/ It just got approved by FDA for covid shots (and already approved worldwide)

    2/Market expects 26$ EPS for 2022

    3/Covid is not gone after 3 years... we are getting new variants worldwide daily

    4/NVAX data is strong vs variants...

    5/ The company has a lot of cash on its balance sheet (1.8 bn end of September)

    6/ $MRNA $BNTX $PFE $JNJ all sold for more than $50bn of covid products in 2021? (it's a guess, could anyone confirm) I found this on CNBC: "Pfizer expects $32 billion in Covid vaccine sales for 2022, while Moderna is forecasting at least $19 billion in sales."

    7/ Market cap of $NVAX is 5 bn

    SURE you tell your manager, I don't feel like buying

    If you don't buy this? Change job, don't you agree?

    I've very rarely seen such a cheap stock pharma/biotech on all metrics, with real products, producing cash and huge potential (of course to be confirmed)
  • N
    Nat
    WiMi Hologram Cloud Inc.
    $WIMI $BNTX Keep it up! Thank you!
  • N
    Nat
    WiMi Hologram Cloud Inc.
    $WIMI $BNTX Look down, not up, when making your initial investment decision. If you don’t lose money, most of the remaining alternatives are good ones
  • N
    Nat
    WiMi Hologram Cloud Inc.
    $WIMI $BNTX I like the stock.
  • N
    Nat
    WiMi Hologram Cloud Inc.
    $WIMI $BNTX Here is part of the tradeoff with diversification. You must be diversified enough to survive bad times or bad luck so that skill and good process can have the chance to pay off over the long term.
  • i
    investfordummies
    $NVAX conversation
    Are $PFE $MRNA $BNTX down with this $NVAX rumor?
  • i
    investfordummies
    $NVAX conversation
    What is the risk that any big pharma like $PFE $JNJ buys $NVAX $BNTX $MRNA outright?

    Now they all have covid shots approved $NVAX since yesterday
    They all have a lot of cash on their balance sheet
    And are trading at 2022 PE of about 2 (ex-cash) for $NVAX and in any case much lower than 5 for all the 3 names...

    Anyone?
  • T
    Titos
    $NVAX conversation
    Yahoo News: "Incidence rate for Novavax's adverse reactions higher than other COVID vaccines: HSA data" $BNTX $NVAX
  • S
    Stark
    $NVAX conversation
    $Mrna $bntx

    The need for the Novavax vaccine is greater than ever.

    What does the data really show for the updated mRNA vaccines?

    To me what was expected and certainly both Pfizer’s and Moderna bi-valent vaccine will be approved. Yet the flaw with mRNA is as glaring and enormous as ever. Proves that they are continuously playing catch up and mRNA has failed as a platform. Basically 1.5 times the antibody response at 1 month for Ba1 . Much less for the newer sub variants. What variants will be circulating in the fall? The dead of winter? What will be the level of antibodies for those variants at 3 months 4 months.? Most likely the same pattern of rapid waning and minimal protection.
    What if a really virulent variant arrives . This is a stop gap and the need for a more durable vaccine exists and is needed.
    Multiple reasons for an alternative to mRNA .

    The future is a pan -coronavirus universal vaccine and Novavax has the best path forward because it’s dosage independent. Remember and think about this, Pfizer raising the dosage to try and get a better immune response in adults. So a 50 year old 100 pound women should get 60 mcg? YET let’s say a 17 year old male 200 pounds going away to a infested college dorm this fall only gets 10 mcg? How absurd!
    The Novavax vaccine is dosage independent using the same dosage in all age groups.

    Sure Novavax will introduce a bi-valent vaccine soon, however it’s a 6- valent, maybe 8-valent vaccine that targets all parts of the spike including the non mutating areas.

    We have a seat at the table , hoping for a FDA approval on Monday.
    At the meeeting we can acknowledge the need for a bi-valent Omicron enhanced vaccine . Im sure the FDA will be interested in hearing the progress of our vaccine as well.

    Novavax is the future and will be the ultimate winner in the control of this plague.